|
patients | Baseline | After 3 months | After 6 months | After 12 months |
|
ESR (mm/h) | 24.5 (5–82) {95% CI: 14.3–36.0} | 14.0 (3–74)* {95% CI: 8.0–29.5} | 19.0 (3–120) {95% CI: 7.5–38.3} | 14.5 (3–94) {95% CI: 9.8–36.8} |
CRP (mg/L) | 4.1 (0.2–119) {95% CI: 2.0–9.2} | 3.0 (0.3–34.8)* {95% CI: 1.1–5.9} | 3.0 (0.2–38.1) {95% CI: 1.0–6.8} | 3.6 (0.0–65) {95% CI: 1.4–7.5} |
DAS28 | 4.8 (1.6–8.0) {95% CI: 4.1–6.1} | 4.1 (1.4–7.6)* {95% CI: 2.9–4.9} | 3.7 (1.1–6.8)* {95% CI: 2.5–5.2} | 3.8 (1.3–7.1)* {95% CI: 2.8–4.7} |
Synovitis score in GSUS (0–27) | 13.0 (7–25) {95% CI: 0.5–6.5} | 10.0 (3–22)* {95% CI: 6.5–15.0} | 10.0 (2–18)* {95% CI: 7.0–13.5} | 9.0 (0–20)* {95% CI: 6.0–12.0} |
Synovitis score in PDUS (0–39) | 2.0 (0–16) {95% CI: 0.5–6.5} | 1.0 (0–20) {95% CI: 0.0–5.0} | 1.0 (0–18)* {95% CI: 0.0–3.0} | 2.0 (0–9)* {95% CI: 0.0–2.5} |
Tenosynovitis/paratenonitis score in GSUS (0–7) | 1.0 (0–5) {95% CI: 0.0–1.0} | 0.0 (0–5) {95% CI: 0.0–1.0} | 0.0 (0–3)* {95% CI: 0.0–1.0} | 0.0 (0–5) {95% CI: 0.0–1.0} |
Tenosynovitis/paratenonitis score in PDUS (0–21) | 0.0 (0–8) {95% CI: 0.0–0.0} | 0.0 (0–8) {95% CI: 0.0–0.0} | 0.0 (0–5) {95% CI: 0.0–0.0} | 0.0 (0–6) {95% CI: 0.0–0.0} |
Erosions score excluding the wrist (0–14) | 7.0 (0–14) {95% CI: 4.0–9.0} | 6.0 (1–14) {95% CI: 4.0–9.0} | 6.0 (0–14) {95% CI: 4.0–9.0} | 5.0 (0–11)* {95% CI: 3.0–7.0} |
Erosions score including the wrist (0–17) | 8.0 (0–17) {95% CI: 5.0–11.0} | 7.0 (2–17) {95% CI: 6.0–11.5} | 8.0 (0–17) {95% CI: 5.0–11.5} | 6.0 (1–14)* {95% CI: 5.0–9.0} |
|